Abstract
Over the past two decades, catatonia, particularly its acutely emerging akinetic-hypokinetic (stuporous) variant, has gradually regained its importance in descriptive psychopathology. Electroconvulsive therapy and lately benzodiazepines are not only effective treatment options in this form of catatonia, but also helped generate neurobiological hypotheses concerning its pathophysiology. Within this broad framework, this paper summarizes the results of recent benzodiazepine treatment response studies in catatonic movement disorders with particular reference to the authors' own studies in Chinese patients with catatonia.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ungvari, G., Kau, L., Wai-Kwong, T. et al. The pharmacological treatment of catatonia: an overview. European Archives of Psychiatry and Clinical Neurosciences 251 (Suppl 1), I31–I34 (2001). https://doi.org/10.1007/PL00014198
Issue Date:
DOI: https://doi.org/10.1007/PL00014198